ongoing trials trial from www.clinicaltrials.gov Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management - Not yet recruiting Year: 2019 Date: November 1, 2019 Author: University of Colorado, Denver|Cystic Fibrosis Foundation Source https://ClinicalTrials.gov/show/NCT03939065 Study design (if review, criteria of inclusion for studies) Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment Participants Cystic Fibrosis-related Diabetes|Cystic Fibrosis Pulmonary Exacerbation|Cystic Fibrosis in Children - 8 Years to 25 Years (Child, Adult) Interventions Device: Sensor Augmented Pump Therapy|Device: Standard of Care with CGM Outcome measures Differences in CGM percent time over 140 mg/dl|Change in Pulmonary Function|Circulatory markers of inflammation|Weight change|Statstrip glucose Related topics Abnormal glucose metabolism therapy